PubMed Health⌕ Search

Biomedical subjects

D Kelsey

Publications and source records attributed to D Kelsey.

9 recordsLinked to original sources
PubMed2001

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

OBJECTIVE: Atomoxetine is an investigational, nonstimulant pharmacotherapy being studied as potential treatment for attention-deficit/hyperactivity disorder (ADHD). It is thought to act via blockade of the presynaptic norepinephrine transporter in the brain. We assessed the efficacy of 3 doses of atomoxetine compared with placebo in children and adolescents with ADHD. METHODS: A total of 297 children and adolescents who were 8 to 18 years of age and had ADHD as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, were randomized to placebo or atomoxetine dosed on a weight-adjusted basis at 0.5 mg/kg/day, 1.2 mg/kg/day, or 1.8 mg/kg/day for an 8-week period. ADHD symptoms, affective symptoms, and social and family functioning were assessed using parent and investigator rating scales. RESULTS: Approximately 71% of children enrolled were male, approximately 67% met criteria for mixed subtype (both inattentive and hyperactive/impulsive symptoms), and the only common psychiatric comorbidity was oppositional defiant disorder (approximately 38% of the sample). At baseline, symptom severity was rated as moderate to severe for most children. At endpoint, atomoxetine 1.2 mg/kg/day and 1.8 mg/kg/day were consistently associated with superior outcomes in ADHD symptoms compared with placebo and were not different from each other. The dose of 0.5 mg/kg/day was associated with intermediate efficacy between placebo and the 2 higher doses, suggesting a graded dose-response. Social and family functioning also were improved in the atomoxetine groups compared with placebo with statistically significant improvements in measures of children's ability to meet psychosocial role expectations and parental impact. Discontinuations as a result of adverse events were <5% for all groups. CONCLUSION: Among children and adolescents aged 8 to 18, atomoxetine was superior to placebo in reducing ADHD symptoms and in improving social and family functioning symptoms. Atomoxetine was associated with a graded dose-response, and 1.2 mg/kg/day seems to be as effective as 1.8 mg/kg/day and is likely to be the appropriate initial target dose for most patients. Treatment with atomoxetine was safe and well tolerated.

Adolescent↗
PubMed1997

Design of the femoral component for cementless hip replacement: the surgeon's perspective.

Few guidelines are currently available to the surgeon when choosing a specific femoral component for cementless total hip replacement (THR). A survey of the members of the American Association for Hip and Knee Surgeons (AAHKS) was conducted to gain insight into the importance of implant material, stress shielding, and micromotion in the selection of cementless femoral components. A comprehensive survey was distributed to 300 orthopedic surgeons selected from the members of the AAHKS; 169 of the 300 surgeons completed the detailed questionnaire. The results of the survey were analyzed using the SPSS software package to obtain general trends in opinion, and a stepwise regression analysis was used to correlate responses with training and clinical experience. Interestingly, there was little consensus among surgeons with respect to the relative importance of implant material, stress shielding, and micromotion in the selection of prostheses for cementless THR. In general, bone loss secondary to stress shielding was the least important issue, and axial and rotational micromotion were considered progressively more significant problems. Cementless titanium alloy stems were perceived as offering no significant advantage over cobalt chrome alloy stems. Moreover, there was no consensus as to whether a collar was advantageous. Prosthesis stability, restoration of motion, and a proven clinical record were more important to surgeons than were ease of implantation and removal, cost, and availability.

Bone Cements↗
PubMed1995

Case report: ultrasound and MRI findings in a scrotal epidermoid cyst.

Intrascrotal masses in the adult are worrisome due to their possible malignancy. Most intratesticular masses are malignant whereas most extratesticular masses are benign. The differential diagnosis of intrascrotal cysts usually includes simple testicular cysts, intratesticular epidermoid and dermoid cysts, tunica albuginea cysts, epididymal cysts and spermatoceles [1-7]. This case report describes a large epidermoid cyst of the scrotum presenting as an enlarging scrotal tumour.

Aged↗
PubMed1989

Phosphorus nuclear magnetic resonance studies of lipid-protein interactions: human erythrocyte glycophorin and phospholipids.

Human erythrocyte glycophorin containing four molecules of phospholipid tightly bound to the protein was isolated from human red cell ghosts. This protein preparation was reconstituted into a digalactosyl diglyceride bilayer. The 31P NMR spectrum of this reconstituted membrane produced an axially symmetric powder pattern arising exclusively from the phospholipids bound to glycophorin. The width of the powder pattern, about 90 ppm, is about twice as broad as that normally exhibited by a phospholipid bilayer. The chemical shift tensor is perturbed relative to phospholipids in a bilayer. The spin-lattice relaxation rate of these protein-bound phospholipids is found to be nearly an order of magnitude faster than phospholipids in a bilayer. The results are consistent with phospholipids tightly bound to the membrane protein and undergoing rotational diffusion, perhaps as a complex of phospholipid and protein.

Erythrocyte Membrane↗